Your browser doesn't support javascript.
loading
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.
Stohl, William; Merrill, Joan T; Looney, R John; Buyon, Jill; Wallace, Daniel J; Weisman, Michael H; Ginzler, Ellen M; Cooke, Blaire; Holloway, Donna; Kaliyaperumal, Arunan; Kuchimanchi, Kameswara Rao; Cheah, Tsui Chern; Rasmussen, Erik; Ferbas, John; Belouski, Shelley S; Tsuji, Wayne; Zack, Debra J.
Afiliação
  • Stohl W; Los Angeles County and University of Southern California Medical Center and University of Southern California Keck School of Medicine, 1975 Zonal Ave., Los Angeles, CA, 90033, USA. stohl@usc.edu.
  • Merrill JT; Division of Rheumatology, Los Angeles County + University of Southern California Medical Center and Keck School of Medicine of the University of Southern California, 2011 Zonal Ave., Los Angeles, CA, 90033, USA. stohl@usc.edu.
  • Looney RJ; Oklahoma Medical Research Foundation, 825 NE 13th St., Oklahoma City, OK, 73104, USA. JTMmail@aol.com.
  • Buyon J; University of Rochester, 252 Elmwood Ave., Rochester, NY, 14627, USA. John_Looney@URMC.Rochester.edu.
  • Wallace DJ; Hospital for Joint Disease, 301 E 17th St., New York, NY, 10003, USA. Jbuyonic@aol.com.
  • Weisman MH; Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA, 90048, USA. drdanielwallace@gmail.com.
  • Ginzler EM; Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA, 90048, USA. Michael.Weisman@cshs.org.
  • Cooke B; SUNY Downstate Medical Center, 450 Clarkson Ave., Brooklyn, NY, 11203, USA. ELLEN.GINZLER@downstate.edu.
  • Holloway D; Amgen Inc., 1 Amgen Center Dr., Thousand Oaks, CA, 91320, USA. bcooke@amgen.com.
  • Kaliyaperumal A; Formerly of Amgen, Inc., 1 Amgen Center Dr., Thousand Oaks, CA, 91320, USA. donnalholloway@yahoo.com.
  • Kuchimanchi KR; Amgen Inc., 1 Amgen Center Dr., Thousand Oaks, CA, 91320, USA. arunank@amgen.com.
  • Cheah TC; Formerly of Amgen, Inc., 1 Amgen Center Dr., Thousand Oaks, CA, 91320, USA. Kamesh.Kuchimanchi@baxalta.com.
  • Rasmussen E; Amgen Inc., 1 Amgen Center Dr., Thousand Oaks, CA, 91320, USA. tcheah@amgen.com.
  • Ferbas J; Amgen Inc., 1 Amgen Center Dr., Thousand Oaks, CA, 91320, USA. hansr@amgen.com.
  • Belouski SS; Amgen Inc., 1 Amgen Center Dr., Thousand Oaks, CA, 91320, USA. jferbas@amgen.com.
  • Tsuji W; Formerly of Amgen, Inc., 1 Amgen Center Dr., Thousand Oaks, CA, 91320, USA. sbelouski@yahoo.com.
  • Zack DJ; Amgen Inc., 1 Amgen Center Dr., Thousand Oaks, CA, 91320, USA. tsujiw@amgen.com.
Arthritis Res Ther ; 17: 215, 2015 Aug 20.
Article em En | MEDLINE | ID: mdl-26290435
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Subpopulações de Linfócitos B / Fator Ativador de Células B / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Subpopulações de Linfócitos B / Fator Ativador de Células B / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article